Gerresheimer, a leading provider of pharmaceutical packaging and drug delivery systems, has received an A- rating in the latest CDP (Carbon Disclosure Project) climate assessment. This score places the company in the “Leadership” category, significantly outperforming both the global and industry averages, which remain at a C rating.
CDP is the world’s leading platform for environmental disclosure, evaluating thousands of companies annually based on their climate strategies, emissions data, and environmental governance. Gerresheimer’s strong performance reflects its long-term commitment to sustainability, anchored in its corporate strategy formula g.
Since 2011, Gerresheimer has consistently reported its environmental impact through CDP. The company was recognized for excellence in multiple categories, including emissions reduction initiatives, low-carbon product development, risk management, and data verification.
A cornerstone of Gerresheimer’s environmental agenda is its target to reduce Scope 1 and Scope 2 greenhouse gas emissions by 50% by 2030, using 2019 as a baseline. These scopes cover both direct emissions from operations and indirect emissions from purchased electricity. By the end of 2024, Gerresheimer had already achieved a 28% reduction, with 55% of its electricity sourced from renewables—a major step toward its goal of reaching 100% renewable electricity by 2030. 
Gerresheimer is continuing to invest in modern production technologies to lower energy use and further reduce emissions. Its A- CDP score is a testament to its progress and leadership in climate responsibility, setting a strong example for the global industrial sector.
Source: Gerresheimer with additional information added by Glass Balkan
